684 results on '"Nout, Remi A"'
Search Results
2. Automated causal inference in application to randomized controlled clinical trials
3. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
4. Time-action and patient experience analyses of locally advanced cervical cancer brachytherapy
5. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
6. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
7. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
8. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
9. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer
10. ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer
11. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
12. Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
13. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
14. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer
15. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
16. GEC-ESTRO (ACROP)–ABS–CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina
17. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
18. Postgraduate education in radiation oncology during the COVID-19 pandemic – What did we learn?
19. Prediction of recurrence risk in endometrial cancer with multimodal deep learning
20. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
21. Automated causal inference in application to randomized controlled clinical trials
22. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study
23. Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
24. Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
25. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer
26. Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile
27. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
28. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
29. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
30. RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
31. Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors
32. Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy
33. Multibody dynamic modeling of the behavior of flexible instruments used in cervical cancer brachytherapy
34. Uterine serous carcinoma
35. Drug repurposing as a potential source of innovative therapies in cervical cancer
36. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
37. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
38. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
39. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study
40. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
41. Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer
42. Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective
43. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
44. Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer
45. Late, Persistent, Substantial, Treatment-Related Symptoms After Radiation Therapy (LAPERS): A New Method for Longitudinal Analysis of Late Morbidity—Applied in the EMBRACE Study
46. HECTOR: multimodal deep learning predicts recurrence risk in endometrial cancer.
47. SO019LBA/#875 Molecular features predicts outcomes in multicentric international study of chemoradiation and MRI based image guided brachytherapy for cervical cancer (EMBRACE): final analysis from bioembrace-I
48. SO006/#55 Regular dilation and/or sexual activity show less risk for vaginal stenosis in cervical cancer patients
49. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
50. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, -2 and -3 trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.